NCT00543504 2020-06-30Bevacizumab in Multiple Phase I CombinationsM.D. Anderson Cancer CenterPhase 1 Completed343 enrolled
NCT00785226 2016-10-17RDEA119 and Sorafenib Combination Dose Escalation StudyBayerPhase 1/2 Completed62 enrolled